Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
08 Feb 2024
Historique:
received: 21 02 2023
accepted: 15 12 2023
medline: 9 2 2024
pubmed: 19 12 2023
entrez: 19 12 2023
Statut: epublish

Résumé

Hidradenitis suppurativa (HS) is a chronic skin condition affecting approximately 1% of the US population. HS skin lesions are highly inflammatory and characterized by a large immune infiltrate. While B cells and plasma cells comprise a major component of this immune milieu, the biology and the contribution of these cells in HS pathogenesis are unclear. We aimed to investigate the dynamics and microenvironmental interactions of B cells within cutaneous HS lesions. Combining histological analysis, single-cell RNA sequencing, and spatial transcriptomics profiling of HS lesions, we defined the tissue microenvironment relative to B cell activity within this disease. Our findings identified tertiary lymphoid structures (TLSs) within HS lesions and described organized interactions among T cells, B cells, antigen-presenting cells, and skin stroma. We found evidence that B cells within HS TLSs actively underwent maturation, including participation in germinal center reactions and class switch recombination. Moreover, skin stroma and accumulating T cells were primed to support the formation of TLSs and facilitate B cell recruitment during HS. Our data definitively demonstrated the presence of TLSs in lesional HS skin and point to ongoing cutaneous B cell maturation through class switch recombination and affinity maturation during disease progression in this inflamed nonlymphoid tissue.

Identifiants

pubmed: 38113104
pii: 169870
doi: 10.1172/jci.insight.169870
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR075864
Pays : United States

Commentaires et corrections

Type : UpdateOf

Auteurs

Margaret M Lowe (MM)

Department of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.

Jarish N Cohen (JN)

Department of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.

Madison I Moss (MI)

Department of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.

Sean Clancy (S)

Department of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.

James P Adler (JP)

Bioinformatics and Genomics master's program, University of Oregon, Eugene, Oregon, USA.
Cancer Early Detection Advanced Research Center, Oregon Health & Science University (OHSU), Portland, Oregon, USA.

Ashley E Yates (AE)

Department of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.

Haley B Naik (HB)

Department of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.

Rashi Yadav (R)

Cancer Early Detection Advanced Research Center, Oregon Health & Science University (OHSU), Portland, Oregon, USA.

Mariela Pauli (M)

TRex Bio, South San Francisco, California, USA.

Ian Taylor (I)

TRex Bio, South San Francisco, California, USA.

Austin McKay (A)

TRex Bio, South San Francisco, California, USA.

Hobart Harris (H)

Department of Surgery, UCSF, San Francisco, California, USA.

Esther Kim (E)

Department of Surgery, UCSF, San Francisco, California, USA.

Scott L Hansen (SL)

Department of Surgery, UCSF, San Francisco, California, USA.

Michael D Rosenblum (MD)

Department of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.

Joshua M Moreau (JM)

Cancer Early Detection Advanced Research Center, Oregon Health & Science University (OHSU), Portland, Oregon, USA.
Division of Oncological Sciences.
Department of Dermatology, and.
Department of Cell, Developmental and Cancer Biology, OHSU, Portland, Oregon, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH